🇺🇸 FDA
Pipeline program

PLACEBO DE COLCHICINE 1 mg, COLCHICINE OPOCALCIUM 1 mg, comprimé sécable

APHP211429

Phase 3 small_molecule active

Quick answer

PLACEBO DE COLCHICINE 1 mg, COLCHICINE OPOCALCIUM 1 mg, comprimé sécable for patients suffering from acute myocarditis confirmed on Cardiac magnetic resonance imaging. is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
patients suffering from acute myocarditis confirmed on Cardiac magnetic resonance imaging.
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials